Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sizhi P Gao

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|December 3, 2025
Editorial: Histone modifications in cancerJiaqian Luo, Sizhi P Gao
Breast Cancer Research : BCR|October 9, 2010
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformationKenneth Leslie, Sizhi P Gao, Marjan Berishaj, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2016
A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR-Mutant Lung Adenocarcinomas with Acquired Resistance to ErlotinibHelena A Yu, Leslie Perez, Qing Chang, et al.
Oncotarget|February 5, 2016
Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signalingFanfan Zhu, Chunyan Dai, Yufei Fu, et al.
Journal of the National Cancer Institute|January 14, 2010
Paracrine regulation of pancreatic cancer cell invasion by peripheral nervesZiv Gil, Oren Cavel, Kaitlyn Kelly, et al.
Science Signaling|March 31, 2016
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitorsSizhi P Gao, Qing Chang, Ninghui Mao, et al.
Nature Genetics|January 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promotersNaitao Wang, Mohini R Pachai, Dan Li, et al.
Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial CancerJudit Börcsök, Zsofia Sztupinszki, Raie Bekele, et al.
Nature Communications|April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenograftsKwanghee Kim, Wenhuo Hu, François Audenet, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|December 3, 2025
Editorial: Histone modifications in cancerJiaqian Luo, Sizhi P Gao
Breast Cancer Research : BCR|October 9, 2010
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformationKenneth Leslie, Sizhi P Gao, Marjan Berishaj, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2016
A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR-Mutant Lung Adenocarcinomas with Acquired Resistance to ErlotinibHelena A Yu, Leslie Perez, Qing Chang, et al.
Oncotarget|February 5, 2016
Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signalingFanfan Zhu, Chunyan Dai, Yufei Fu, et al.
Journal of the National Cancer Institute|January 14, 2010
Paracrine regulation of pancreatic cancer cell invasion by peripheral nervesZiv Gil, Oren Cavel, Kaitlyn Kelly, et al.
Science Signaling|March 31, 2016
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitorsSizhi P Gao, Qing Chang, Ninghui Mao, et al.
Nature Genetics|January 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promotersNaitao Wang, Mohini R Pachai, Dan Li, et al.
Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial CancerJudit Börcsök, Zsofia Sztupinszki, Raie Bekele, et al.
Nature Communications|April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenograftsKwanghee Kim, Wenhuo Hu, François Audenet, et al.
Pageof 2